LYCOS RETRIEVER 
Genetics: Targeted Genetics
built 608 days ago
Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at http://www.targetedgenetics.com.
Source:
The field of human genetics has been energized in recent years by the Human Genome Project, an international collaboration of scientists, governments, and drug companies from around the world. Scientists working on this project have developed detailed maps that identify the chromosomal locations of the estimated 20,000 to 25,000 human genes. The vast databases emerging from the project help scientists study previously unknown genes as well as many genes all at once to examine how gene activity can cause disease. Scientists expect that the project will lead to the development of new drugs targeted to specific genetic disorders.
Source:
"We appreciate the collaborative efforts of the parties involved in the review and the thorough analysis of the available data," said H. Stewart Parker, president and chief executive officer of Targeted Genetics. "Over the next several weeks, we will work with trial sites to obtain approval from Institutional Review Boards and reconsent the patients eligible to receive the second injection."
Source:
MORE ABOUT
Targeted Genetics